Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Using intermittent theta burst stimulation to treat fibromyalgia

Official title: The Effect of Intermittent Theta Burst Stimulation to the Primary Motor Cortex on Pain Intensity, Pain Catastrophizing, Quality of Life and Mood in Fibromyalgia Patients

Run by Izmir Katip Celebi University · NCT06746922 · Data updated 2026-11-12

This study is testing if a new brain stimulation technique can help people with fibromyalgia feel less pain and manage their symptoms better.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment30 (estimated)
SponsorIzmir Katip Celebi University
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Izmir, Karabaglar)
StatusRecruiting
StartedMarch 13, 2025
Main results expectedFebruary 1, 2027
Study endsApril 1, 2027
Registry record updatedMarch 18, 2025
Trial IDNCT06746922 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18-65 diagnosed with fibromyalgia syndrome and experiencing moderate to severe pain.

Probably not a fit

Patients with contraindications for transcranial magnetic stimulation, such as those with metallic implants or serious neurological conditions, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of intermittent theta burst stimulation (iTBS), a form of repetitive transcranial magnetic stimulation (rTMS), on patients diagnosed with fibromyalgia syndrome. It aims to include at least 30 participants aged 18-65 who have been experiencing chronic pain and other symptoms associated with fibromyalgia. The study will compare the effects of active iTBS treatment against a sham treatment to evaluate its efficacy in pain relief and symptom management. The research is being conducted at İzmir Katip Çelebi University Atatürk Training and Research Hospital, focusing on a population that has stable fibromyalgia treatment for the past three months.

Why it matters

Potential benefit: If successful, this treatment could provide significant pain relief and improve the quality of life for patients suffering from fibromyalgia.

How similar studies have gone: While there is increasing research on rTMS for fibromyalgia, this specific approach using iTBS is relatively novel and has not been widely tested in the literature.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Being between the ages of 18-65
* Being diagnosed with fibromyalgia syndrome (according to 2016 criteria)
* Average pain intensity of NRS ≥ 4/10
* Fibromyalgia treatment was stable for the last 3 months and no treatment change was planned during the study

Exclusion Criteria:

* Having a clinical condition that would constitute a contraindication for TMS (metallic implant, cardiac pacing, pregnancy, epilepsy, head trauma, history of cranial operation...)
* Presence of malignancy
* Systemic rheumatologic diseases
* Major orthopedic problems limiting activities of daily living (gait disturbance or fracture sequelae limiting joint mobility, prostheses, nerve-tendon injuries)
* Serious neurological diseases (increased intracranial pressure, presence of space-occupying lesions in the brain, history of epilepsy, presence of cerebral aneurysm, Parkinson's disease, Huntington's chorea, multiple sclerosis, history of previous head trauma causing loss of consciousness)
* Alcohol or drug addiction
* History of major depression/personality disorder or psychosis
* Having received TMS treatment before
* Taking benzodiazepine, gabapentin/pregabalin or anticonvulsant medications that have the potential to interfere with intermittent theta burst stimulation treatment or have taken them within the last 4 weeks
* Pregnant or planning pregnancy or breastfeeding

Where it's running

  • Izmir Katip Çelebi University Atatürk Training and Research Hospital
    Izmir, Karabaglar, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.